ArticleJournal of immunology (Baltimore, Md. : 1950)2016
LAG-3 Confers a Competitive Disadvantage upon Antiviral CD8+ T Cell Responses.
Kevin D Cook et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
17 papers cite it
this papercites it